Medicine, McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada
Medicine, University of Calgary, Calgary, Alberta, Canada.
BMJ Open. 2020 Oct 21;10(10):e041733. doi: 10.1136/bmjopen-2020-041733.
Gut microbiome and diet may be important in irritable bowel syndrome (IBS), inflammatory bowel disease (IBD) and comorbid psychiatric conditions, but the mechanisms are unclear. We will create a large cohort of patients with IBS, IBD and healthy controls, and follow them over time, collecting dietary and mental health information and biological samples, to assess their gastrointestinal (GI) and psychological symptoms in association with their diet, gut microbiome and metabolome.
This 5-year observational prospective cohort study is recruiting 8000 participants from 15 Canadian centres. Persons with IBS who are 13 years of age and older or IBD ≥5 years will be recruited. Healthy controls will be recruited from the general public and from friends or relatives of those with IBD or IBS who do not have GI symptoms. Participants answer surveys and provide blood, urine and stool samples annually. Surveys assess disease activity, quality of life, physical pain, lifestyle factors, psychological status and diet. The main outcomes evaluated will be the association between the diet, inflammatory, genetic, microbiome and metabolomic profiles in those with IBD and IBS compared with healthy controls using multivariate logistic regression. We will also compare these profiles in those with active versus quiescent disease and those with and without psychological comorbidity.
Approval has been obtained from the institutional review boards of all centres taking part in the study. We will develop evidence-based knowledge translation initiatives for patients, clinicians and policymakers to disseminate results to relevant stakeholders. NCT03131414.
肠道微生物组和饮食可能在肠易激综合征(IBS)、炎症性肠病(IBD)和并存的精神疾病中起重要作用,但机制尚不清楚。我们将创建一个由大量 IBS、IBD 和健康对照患者组成的队列,并对他们进行随访,收集饮食和心理健康信息及生物样本,以评估他们的胃肠道(GI)和心理症状与他们的饮食、肠道微生物组和代谢组的关系。
这是一项为期 5 年的观察性前瞻性队列研究,正在从加拿大的 15 个中心招募 8000 名参与者。将招募年龄在 13 岁及以上的 IBS 患者或患病 5 年以上的 IBD 患者。健康对照者将从普通人群以及那些没有 GI 症状的 IBD 或 IBS 患者的朋友或亲戚中招募。参与者每年回答调查问题并提供血液、尿液和粪便样本。调查评估疾病活动度、生活质量、身体疼痛、生活方式因素、心理状态和饮食。使用多变量逻辑回归评估 IBD 和 IBS 患者与健康对照组之间饮食、炎症、遗传、微生物组和代谢组谱的主要结果。我们还将比较这些谱在活动期与缓解期疾病、有和无心理共病的患者之间的差异。
所有参与研究的中心的机构审查委员会均已批准该研究。我们将为患者、临床医生和决策者制定循证知识转化计划,将研究结果传播给相关利益攸关方。NCT03131414。